He recommended that, “Johnson & Johnson should immediately respond with clear facts about who is at risk, that no health authority recommends mixing vaccines after one is taken, and how their vaccine is internally and externally monitored. Officials should focus on the fact that it was the company that presented all side effect information to the FDC and the CDC in the first place.”, the principal of PR Security Service, was not so optimistic.
“Lastly, I’d also recommend J&J provide key insights into other remedies they are developing to combat Covid similar to what Pfizer is doing. All of this should be message[d] in a way that emphasizes their expertise and commitment to saving lives. The time for the company to start this is yesterday.”, a professor of information design and corporate communication at Bentley University, thought that, “The voting result from the panel put J&J’s vaccine in a negative spotlight.